Photo of Tariq Kewan taken from Yale Cancer Center/LinkedIn
Dec 16, 2023, 16:26
TP53 has a negative impact on survival, but not on response to HMA – Yale Cancer Center
Quoting Yale Cancer Center on X/Twitter:
“Tariq Kewan, presents a review of VALIDATE database of MDS pts with TP53 treated with HMA ASH23:
– TP53 has a negative impact on survival, but not on response to HMA,
– Patients with TP53 have poor outcomes and need of new therapies.”
Source: Yale Cancer Center/X
